These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31924226)

  • 1. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.
    El Gaamouch F; Audrain M; Lin WJ; Beckmann N; Jiang C; Hariharan S; Heeger PS; Schadt EE; Gandy S; Ehrlich ME; Salton SR
    Mol Neurodegener; 2020 Jan; 15(1):4. PubMed ID: 31924226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.
    Cho K; Jang YJ; Lee SJ; Jeon YN; Shim YL; Lee JY; Lim DS; Kim DH; Yoon SY
    Biochem Biophys Res Commun; 2020 Apr; 524(3):764-771. PubMed ID: 32037089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.
    Elmadany N; de Almeida Sassi F; Wendt S; Logiacco F; Visser J; Haage V; Hernandez DP; Mertins P; Hambardzumyan D; Wolf S; Kettenmann H; Semtner M
    J Neurosci; 2020 Apr; 40(17):3320-3331. PubMed ID: 32060170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.
    Hannedouche S; Beck V; Leighton-Davies J; Beibel M; Roma G; Oakeley EJ; Lannoy V; Bernard J; Hamon J; Barbieri S; Preuss I; Lasbennes MC; Sailer AW; Suply T; Seuwen K; Parker CN; Bassilana F
    J Biol Chem; 2013 Sep; 288(38):27434-27443. PubMed ID: 23940034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular identity of the TLQP-21 peptide receptor.
    Sahu BS; Nguyen ME; Rodriguez P; Pallais JP; Ghosh V; Razzoli M; Sham YY; Salton SR; Bartolomucci A
    Cell Mol Life Sci; 2021 Dec; 78(23):7133-7144. PubMed ID: 34626205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.
    Cero C; Vostrikov VV; Verardi R; Severini C; Gopinath T; Braun PD; Sassano MF; Gurney A; Roth BL; Vulchanova L; Possenti R; Veglia G; Bartolomucci A
    Structure; 2014 Dec; 22(12):1744-1753. PubMed ID: 25456411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.
    Doolen S; Cook J; Riedl M; Kitto K; Kohsaka S; Honda CN; Fairbanks CA; Taylor BK; Vulchanova L
    Glia; 2017 Dec; 65(12):1976-1989. PubMed ID: 28850719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.
    Cero C; Razzoli M; Han R; Sahu BS; Patricelli J; Guo Z; Zaidman NA; Miles JM; O'Grady SM; Bartolomucci A
    Mol Metab; 2017 Jan; 6(1):148-158. PubMed ID: 28123945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.
    Tsai AP; Dong C; Lin PB; Messenger EJ; Casali BT; Moutinho M; Liu Y; Oblak AL; Lamb BT; Landreth GE; Bissel SJ; Nho K
    Genome Med; 2022 Feb; 14(1):17. PubMed ID: 35180881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice.
    Harder JM; Williams PA; Braine CE; Yang HS; Thomas JM; Foxworth NE; John SWM; Howell GR
    J Neuroinflammation; 2020 Nov; 17(1):336. PubMed ID: 33176797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
    Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
    Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21.
    Lisci C; Lewis JE; Daniel ZCTR; Stevenson TJ; Monnier C; Marshall HJ; Fowler M; Ebling FJP; Ferri GL; Cocco C; Jethwa PH
    PLoS One; 2019; 14(8):e0221517. PubMed ID: 31465472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
    Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
    J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLQP-21 is a low potency partial C3aR activator on human primary macrophages.
    Li XX; Lee JD; Lee HS; Clark RJ; Woodruff TM
    Front Immunol; 2023; 14():1086673. PubMed ID: 36776827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
    Natunen T; Martiskainen H; Marttinen M; Gabbouj S; Koivisto H; Kemppainen S; Kaipainen S; Takalo M; Svobodová H; Leppänen L; Kemiläinen B; Ryhänen S; Kuulasmaa T; Rahunen E; Juutinen S; Mäkinen P; Miettinen P; Rauramaa T; Pihlajamäki J; Haapasalo A; Leinonen V; Tanila H; Hiltunen M
    Mol Neurodegener; 2020 Nov; 15(1):66. PubMed ID: 33168021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.